Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model

Journal of Bone and Mineral Research

Volumn 11, Issue 5, 1996, Pages 614-625

  Lane, Nancy E ^a,e   Kimmel, Donald B ^c   Nilsson, Magnus H L ^d   Cohen, Fred E ^a   Newton, Suellen ^a   Nissenson, Robert A ^a,b   Strewler, Gordon J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY   (United States)

^d Karo Bio   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-34][3 HISTIDINE]; PARATHYROID HORMONE[1-34][3 LEUCINE]; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CANCELLOUS BONE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; FEMALE; HUMAN; METAPHYSIS; OSSIFICATION; OSTEOPOROSIS; OSTEOSARCOMA CELL; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA; TRABECULAR BONE;

EID: 0029928651     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110509     Document Type: Article

References (48)

1. Riggs B, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LF 1981 Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin Invest 67:328-335.
2. Hui SL, Slemenda CW, Johnston CC 1990 The contribution of bone loss to postmenopausal osteoporosis. Osteoporosis Int 1:30-34.
3. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM 1985 The role of three dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 37:594-597.
4. Kimmel DB, Recker RR, Gallagher JC, Vaswani A. Aloia JL 1990 A comparison of iliac bone histmorphometry in post-menopausal osteoporotic and normal subjects. Bone Miner 11:217-235.
5. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Larrke AC 1976 Long term prevention of postmenopausal osteoporosis by estrogen. Lancet 50:369-477.
6. Consoli V, Alfieri P, Giuntini M, Manca M, Avaldi F, Soncini R 1991 A double-blind placebo-controlled trial of the efficacy and tolerability of intranasal eleatonin administered to patients suffering from senile and postmenopausal osteoporosis. Curr Ther Res 50:369-377.
7. Watts NB, Harris ST, Genant HK, et al. 1990 Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. New Engl J Med 306:446-450.
8. Hock JM, Gera I, Fonesca J, Raisz LG 1988 Human parathyroid hormone (1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 122:2899-2904.
9. Shen V, Dempster DW, Mellish RWE, Birchman R, Horbert W, Lindsay R 1992 Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17-B estradiol on bone histomorphometry in ovariectomized rats with established osteopenia. Calcif Tissue Int 55:214-220.
10. Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR 1993 The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult, osteopenic, ovairectomized rats. Endocrinology 132:823-831.
11. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OM, Courpron P, Edouard C Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJFE, Potts JT 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicenter trial. Br Med J 280: 1340-1344.
12. 2D. J Bone Miner Res 1:377-381.
13. Wronski TJ, Yen CF, Qi H, Dann LM 1993 Parathyroid hormone is more effective than estrogen or bisphosphonate for restoration of lost bone mass in ovariectomized rats. Endocrinology 123:681-686.
14. Neer RM, Slovik DM, Daly T, Potts JT, Nussbaum SR 1993 Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporosis Int 1:S204-S205.
15. Cohen FE, Strewler GJ, Bradley S, Carlquist M, Nilsson M, Ericsson M, Ciardelli TL, Nissenson RA 1991 Analogues of parathyroid hormone modified at positions 3 and 6. J Biol Chem 266:1997-2004.
16. Chan SDH, Strewler GH, King KL, Nissenson RA 1990 Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells. Mol Endocrinol 4:638-646.
17. Soloman Y, Londos C, Rodbell M 1974 A highly sensitive adenylatc cyclase assay. Anal Biochem 58:541-548.
18. Waynforth HB 1980 Experimental and Surgical Techniques in the Rat. Academic Press, New York.
19. Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA 1985 Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37:324.
20. Kimmel DB, Wronski TJ 1990 Non-destructive measurement of bone mineral in femurs from ovariectomized rats. Calcif Tissue Int 46:101-110.
21. Eskandar E, Kimmel DB, Wronski TJ 1991 Rapid determination of cancellous bone mineral loss in ovariectomized rats by subtraction technique. Anat Rec 230:169-174.
22. Gumberg CN, Hauskchka PV, Lian JB, Gallop M 1984 Osteocalcin: Isolation, characterization, and detection. Meth Enzymol 107:516-544.
23. Seyedin SM, Kung VT, Daniloff YN, Hesley RP 1993 Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 8:639-644.
24. Delmas PJ, Schlemmer A, Gineyts E, Riis B, Christiansen C 1991 Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with osteoporosis. J Bone Miner Res 6:639-644.
25. Villanueva AR, Lundin KD 1989 A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams. Stain Technol 64:129-138.
26. Baron R, Vignery A, Neff L, Silvergate A, Santa Maria A 1983 Processing of undecalcified bone specimen for bone histomorphometry. In: Recker RR (ed.) Bone Histomorphometry: Techniques and Interpretation. CRC, Boca Raton, Florida, pp. 13-35.
27. Goldner J 1938 A modification of the Masson trichrome technique for routine laboratory purposes. Am J Pathol 14:237-243.
28. Maeda H, Kimmel DB, Raab D, Lane NE, 1993 The musculoskeletal response to immobilization and recovery. Bone 14: 153-159.
29. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, et al. 1987 Bone histomorphometry: standardization of nonmencluature, symbols, and units. J Bone Miner Res 2:595-610.
30. Parfitt AM, Mathews CHE, Villanueva AR, Kleerehoper M, Frame B, Rao DS 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:1396-1409.
31. Recker RR 1983 Bone Histomorphometry: Techniques and Interpretations, Vol 1. CRC Press, Boca Raton, Florida.
32. Thorngren KG, Hansson LI 1973 Cell kinetics and morphology of the growth plate in the normal and hypothysectomized rat. Calcif Tissue Res 13:113-129.
33. Kimmel DB 1992 Quantitative histologic changes in the proximal tibia epiphhyseal growth cartilage of aged female rats. Cells Mater 1 (Suppl):11-18.
34. Sokal R, Rohlf FJ 1969 Biometry. Freeman. San Francisco, California.
35. Ryan TA 1960 Significance tests for multiple comparison of proportions, variances, and other statistics. Psychol Bull 57: 318-328.
36. Schipani E, Karga H, Karaplis AC, Potts JT, Kroneaberg HM, Segre GV, Abou-Samra A-B, Juppner H 1993 Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology 132:2157-2165.
37. Gardella TJ, Axelrod D, Rubin D. Keutmann HT, Potts JT Jr, Kronenberg HM, Nussbaum SR 1991 Mutational analysis of the receptor-activating region of human parathyroid hormone. J Biol Chem 266:13141-13146.
38. Nissenson RA, Diep D, Strewler GJ 1988 Synthetic peptides comprising the amino terminal sequences of a parathyroid hormone-like protein from human malignancies. J Biol Chem 263:12866-12871.
39. Orloff JJ, Wu TL. Heath HW, Brady TG, Brines M, Stewart AF 1989 Characterization of canine renal receptors for the parathyroid hormone-like protein associated with humoral hypercalcemia of malignancy. J Biol Chem 264:6097-6103.
40. Tam CS, Heersche JNM, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512.
41. Lui CC, Kalu DN, Salerno E, Echon R, Mollis BW, Ray M 1991 Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. J Bone Miner Res 6:1071-1080.
42. Jerome CP 1994 Analobic effect of high doses of human parathyroid hormone (1-38) in mature intact rats. J Bone Miner Res 9:933-942.
43. Miller SC, Shupe JG, Redd EH, Miller MA, Omura TH 1986 Changes in bone mineral and bone formation rates during pregnancy and lactation in rats. Bone 7:283-287.
44. Gunness-Hey M, Hock JM 1984 Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis 5:177-181.
45. 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 11:103-113.
46. Lindsay R, Cosman F, Nieves J, Dempster D, Shen V 1993 A controlled trial of the effect of 1-34 hPTH in estrogen treated osteoporotic women. J Bone Miner Res 8S1:S130.
47. Wronski TJ 1992 The ovariectomized rat as an animal model of postmenopausal bone loss. Cells Mater 1 (Suppl 1):69-74.
48. Karaplis AC, Luz A, Glowachi J, Bronson RT, Tybulewic VL, Kronenberg HM, Mulligan RC 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289.